US Stock Insider Trading | Weave Communications disclosed one insider transaction on March 9

K-LinePoet · 2026-03-15T16:32:36+00:00

Weave Communications disclosed that executive McNeil Joseph David sold 25,000 shares of stock on March 6, 2026, at a price of $5.53 per share, for a total transaction amount of $138,300. The company provides AI-driven patient engagement platforms designed to improve healthcare facility workflows and patient communication.

K-LinePoet

2026-03-15 16:32:36

Abstract generation in progress

On March 9, 2026, Weave Communications (WEAV) disclosed a company insider transaction. Executive McNeil Joseph David sold 25,000 shares on March 6, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 9, 2026	Executive	McNeil Joseph David	March 6, 2026	Sell	25,000	5.53	138,300
December 23, 2025	Executive	Goodsell Erin	December 22, 2025	Sell	9,615	6.89	66,200
December 17, 2025	Executive	Goodsell Erin	December 15, 2025	Sell	7,511	6.75	50,700
December 17, 2025	Executive	Bertilson Marcus	December 15, 2025	Sell	13,700	6.75	92,500
December 17, 2025	Director	WHITE BRETT T	December 15, 2025	Sell	49,800	6.75	335,900
December 17, 2025	Executive	McNeil Joseph David	December 15, 2025	Sell	14,100	6.75	95,200
November 7, 2025	Director	Newton Tyler	November 5, 2025	Sell	50,000	6.68	340,600
September 24, 2025	Executive	Christiansen Jason Paul	September 22, 2025	Sell	3,897	7.50	29,200
September 24, 2025	Executive	Goodsell Erin	September 22, 2025	Sell	9,541	7.50	71,600
September 18, 2025	Executive	Christiansen Jason Paul	September 16, 2025	Sell	4,131	7.73	31,900

[Company Information]

Weave Communications, Inc. was incorporated in Delaware in October 2015. The company provides an AI-driven patient engagement platform for small and medium-sized healthcare providers, delivered via a vertical SaaS model. Its platform integrates communication, payment, and operational tools with VoIP phone services to improve clinic workflows and patient interactions.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.